Detalhe da pesquisa
1.
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.
Lancet Oncol
; 18(5): 599-610, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28373005
2.
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial.
Lancet Oncol
; 18(5): 587-598, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28373007